share_log

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Monday's After-Market Session

周一盘后交易时段，12只医疗保健股走势
Benzinga Real-time News ·  2022/12/26 16:34

Gainers

获胜者

  • HTG Molecular Diagnostics (NASDAQ:HTGM) shares increased by 70.0% to $5.27 during Monday's after-market session. This security traded at a volume of 1.1 million shares come close, making up 253.2% of its average volume over the last 100 days. The company's market cap stands at $4.8 million.
  • NeuBase Therapeutics (NASDAQ:NBSE) stock rose 16.59% to $0.26. The market value of their outstanding shares is at $8.5 million. As per the press release, Q4 earnings came out 3 days ago.
  • NexImmune (NASDAQ:NEXI) shares rose 15.36% to $0.28. The company's market cap stands at $7.3 million.
  • 180 Life Sciences (NASDAQ:ATNF) shares increased by 15.32% to $1.43. Trading volume for this security closed at 920.4K, accounting for 164.9% of its average full-day volume over the last 100 days. The company's market cap stands at $2.8 million.
  • Pear Therapeutics (NASDAQ:PEAR) stock moved upwards by 14.28% to $1.36. The market value of their outstanding shares is at $189.7 million.
  • Tivic Health Systems (NASDAQ:TIVC) stock rose 13.5% to $0.67. The market value of their outstanding shares is at $6.4 million.
  • HTG 分子诊断 纳斯达克股票代码：HTGM）的股价在周一的盘后交易时段上涨了70.0％，至5.27美元。该证券的交易量接近110万股，占其过去100天平均交易量的253.2％。该公司的市值为480万美元。
  • NeuBase 疗法 纳斯达克股票代码：NBSE）股价上涨16.59％，至0.26美元。他们已发行股票的市值为850万美元。根据新闻稿，第四季度财报在3天前公布。
  • nexiMune 纳斯达克股票代码：NEXI）股价上涨15.36％，至0.28美元。该公司的市值为730万美元。
  • 180 生命科学 纳斯达克股票代码：ATNF）的股价上涨了15.32％，至1.43美元。该证券的交易量收于920.4万，占其过去100天平均全日交易量的164.9％。该公司的市值为280万美元。
  • 梨疗法 纳斯达克股票代码：PEAR）的股票上涨了14.28％，至1.36美元。他们已发行股票的市值为1.897亿美元。
  • Tivic 健康系统 纳斯达克股票代码：TIVC）股价上涨13.5％，至0.67美元。他们已发行股票的市值为640万美元。

Losers

失败者

  • Applied DNA Sciences (NASDAQ:APDN) shares declined by 14.5% to $1.12 during Monday's after-market session. The market value of their outstanding shares is at $14.4 million.
  • MSP Recovery (NASDAQ:MSPR) stock decreased by 8.91% to $1.33. The market value of their outstanding shares is at $98.2 million.
  • Phio Pharma (NASDAQ:PHIO) stock decreased by 6.42% to $0.33. The company's market cap stands at $4.5 million.
  • Aytu BioPharma (NASDAQ:AYTU) shares declined by 6.32% to $0.18. Aytu BioPharma's trading volume hit 87.8K shares by close, accounting for 8.2% of its average volume over the last 100 days. The company's market cap stands at $11.1 million.
  • Acer Therapeutics (NASDAQ:ACER) shares fell 5.92% to $3.5. At the close, Acer Therapeutics's trading volume reached 89.0K shares. This is 27.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $68.2 million.
  • Palisade Bio (NASDAQ:PALI) shares fell 5.76% to $1.8. The company's market cap stands at $2.5 million. See Also:
  • 应用 DNA 科学 纳斯达克股票代码：APDN）股价在周一的盘后交易时段下跌了14.5％，至1.12美元。他们已发行股票的市值为1440万美元。
  • MSP 恢复 纳斯达克股票代码：MSPR）股价下跌8.91％，至1.33美元。他们已发行股票的市值为9,820万美元。
  • 菲奥制药 纳斯达克股票代码：PHIO）股价下跌6.42％，至0.33美元。该公司的市值为450万美元。
  • Aytu 生物制药 纳斯达克股票代码：AYTU）股价下跌6.32％，至0.18美元。Aytu BioPharma的交易量收盘时达到87.8万股，占其过去100天平均交易量的8.2％。该公司的市值为1110万美元。
  • 宏碁疗法 纳斯达克股票代码：ACER）股价下跌5.92％，至3.5美元。收盘时，宏碁Therapeutics的交易量达到8.9万股。这是其过去 100 天平均交易量的27.5％。他们已发行股票的市值为6,820万美元。
  • Palisade Bio 纳斯达克股票代码：PALI）股价下跌5.76％，至1.8美元。该公司的市值为250万美元。 另请参阅：

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自动内容引擎生成，并由编辑审阅。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发